JAN 02, 2021 4:06 PM PST

Drug Re-purposed for COVID-19

WRITTEN BY: Nouran Amin

Pralatrexate, a chemotherapeutic drug originally developed to treat lymphoma, could be repurposed to treat COVID-19—a current ongoing pandemic. The discovery was due to the efforts of novel computational drug screening strategy along with necessary lab experiments.

"We have demonstrated the value of our novel hybrid approach that combines deep-learning technologies with more traditional simulations of molecular dynamics," says Haiping Zhang of the Shenzhen Institutes of Advanced Technology in Shenzhen, China.

Learn more about COVID-19 caused by SARS-CoV-2:

Findings were published in the journal PLOS Computational Biology and suggest that pralatrexate could possibly be therapeutic. However, since the drug was originally based on chemotherapy it can prompt unwanted side-effects. Nevertheless, results are still positive as it points to the advantages of virtual screening.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 19, 2022
Drug Discovery & Development
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
MAY 19, 2022
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
An antibiotic known as clofoctol has shown promise in treating SARS-CoV-2 in mice. The corresponding study was published ...
JUN 06, 2022
Immunology
Using Antibodies to Create Potent Cancer Treatments
JUN 06, 2022
Using Antibodies to Create Potent Cancer Treatments
Cancer can arise from a variety of aberrations that cause cells to divide uncontrollably, and form a tumor. The causes o ...
JUN 13, 2022
Cancer
Clinical Trial Demonstrates an Amazing 100% Response
JUN 13, 2022
Clinical Trial Demonstrates an Amazing 100% Response
The results of a Clinical Trial for rectal cancer patients published last week in the New England Journal of Medicine co ...
JUN 24, 2022
Cannabis Sciences
Decrease in Youth Substance Use During the Pandemic
JUN 24, 2022
Decrease in Youth Substance Use During the Pandemic
A review published in Child and Family Disaster Psychiatry found that youth substance use declined during the COVID-19 p ...
JUL 06, 2022
Drug Discovery & Development
Promising New Treatment Strategy for Psoriasis and Psoriatic Arthrtis
JUL 06, 2022
Promising New Treatment Strategy for Psoriasis and Psoriatic Arthrtis
Researchers have identified a new potential strategy for inhibiting inflammation in both psoriasis and psoriatic arthrit ...
JUL 08, 2022
Cannabis Sciences
$2 Million in NIH Awards go to Study Adolescent Cannabis Use
JUL 08, 2022
$2 Million in NIH Awards go to Study Adolescent Cannabis Use
The NIH's National Institute on Drug Abuse awarded more than $2 million to Indiana University’s Gill Center fo ...
Loading Comments...